Caseware UK (AP4) 2022.0.179 2022.0.179 2023-05-312023-05-31truetrue2022-06-011trueNo description of principal activity1 09619865 2022-06-01 2023-05-31 09619865 2021-06-01 2022-05-31 09619865 2023-05-31 09619865 2022-05-31 09619865 c:Director1 2022-06-01 2023-05-31 09619865 d:CurrentFinancialInstruments 2023-05-31 09619865 d:CurrentFinancialInstruments 2022-05-31 09619865 d:CurrentFinancialInstruments d:WithinOneYear 2023-05-31 09619865 d:CurrentFinancialInstruments d:WithinOneYear 2022-05-31 09619865 d:ShareCapital 2023-05-31 09619865 d:ShareCapital 2022-05-31 09619865 d:RetainedEarningsAccumulatedLosses 2023-05-31 09619865 d:RetainedEarningsAccumulatedLosses 2022-05-31 09619865 c:EntityHasNeverTraded 2022-06-01 2023-05-31 09619865 c:FRS102 2022-06-01 2023-05-31 09619865 c:AuditExempt-NoAccountantsReport 2022-06-01 2023-05-31 09619865 c:FullAccounts 2022-06-01 2023-05-31 09619865 c:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 iso4217:GBP xbrli:pure

Registered number: 09619865









BIOCHROMA LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2023

 
BIOCHROMA LIMITED
REGISTERED NUMBER: 09619865

BALANCE SHEET
AS AT 31 MAY 2023

2023
2022
Note
£
£

  

Current assets
  

Cash at bank and in hand
 4 
212
212

  
212
212

Creditors: amounts falling due within one year
 5 
(855)
(855)

Net current liabilities
  
 
 
(643)
 
 
(643)

Total assets less current liabilities
  
(643)
(643)

  

Net liabilities
  
(643)
(643)


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
(644)
(644)

  
(643)
(643)


Page 1

 
BIOCHROMA LIMITED
REGISTERED NUMBER: 09619865
    
BALANCE SHEET (CONTINUED)
AS AT 31 MAY 2023

For the year ended 31 May 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 20 October 2023.




................................................
George Julian Ward
Director

The notes on pages 3 to 4 form part of these financial statements.

Page 2

 
BIOCHROMA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

1.


General information

The company is a private company limited by shares, incorporated in England. The company is dormant and has not traded in the year.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).


4.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
212
212

212
212


Page 3

 
BIOCHROMA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

5.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other creditors
855
855

855
855



6.


Controlling party

The company is controlled by the director George Julian Ward by virtue of his shareholding, as described in the director's report.

 
Page 4